aTyr Pharma Inc (LIFE)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Sanjay S. Shukla
Employees:
50
10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
8587318389
Are you looking for these stocks instead?
Date | Ratio |
---|---|
2019-07-01 | 1:14 |
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trials for treatment of other interstitial lung diseases (ILDs) The company was incorporated in 2005 and is headquartered in San Diego, California.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|